Cinctive Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Hold	0	–	–	–	561
2022 Q2	–	Sell	-19,200	Closed	-$518K	–	578
2022 Q1	$518K	Buy	+19,200	New	+$518K	0.02%	368